These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9219734)

  • 1. Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro.
    Go Y; Chintala SK; Rayford A; Gagercas E; Ali-Osman F; Venkaiah B; Sawaya R; Gokaslan Z; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1997 Jul; 15(4):447-52. PubMed ID: 9219734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cisplatin and BCNU on MMP-2 levels in human glioblastoma cell lines in vitro.
    Chintala SK; Ali-Osman F; Mohanam S; Rayford A; Go Y; Gokaslan ZL; Gagercas E; Venkaiah B; Sawaya R; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1997 Jul; 15(4):361-7. PubMed ID: 9219724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
    Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
    Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.
    Osmak M; Vrhovec I; Skrk J
    J Neurooncol; 1999 Apr; 42(2):95-102. PubMed ID: 10421065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo.
    Mohanam S; Go Y; Sawaya R; Venkaiah B; Mohan PM; Kouraklis GP; Gokaslan ZL; Lagos GK; Rao JS
    Int J Oncol; 1999 Jan; 14(1):169-74. PubMed ID: 9863025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
    Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2014 Aug; 45(2):887-94. PubMed ID: 24867464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
    Tanabe T
    Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.
    Khoshyomn S; Nathan D; Manske GC; Osler TM; Penar PL
    J Neurooncol; 2002 May; 57(3):193-200. PubMed ID: 12125982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
    Ruan S; Okcu MF; Pong RC; Andreeff M; Levin V; Hsieh JT; Zhang W
    Clin Cancer Res; 1999 Jan; 5(1):197-202. PubMed ID: 9918219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.
    Balaña C; Ramirez JL; Taron M; Roussos Y; Ariza A; Ballester R; Sarries C; Mendez P; Sanchez JJ; Rosell R
    Clin Cancer Res; 2003 Apr; 9(4):1461-8. PubMed ID: 12684420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system.
    Lamy S; Lafleur R; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
    J Cell Biochem; 2007 Jan; 100(1):100-11. PubMed ID: 16823770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.
    Mohanam S; Sawaya R; McCutcheon I; Ali-Osman F; Boyd D; Rao JS
    Cancer Res; 1993 Sep; 53(18):4143-7. PubMed ID: 8395977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCR.
    Sliutz G; Eder H; Koelbl H; Tempfer C; Auerbach L; Schneeberger C; Kainz C; Zeillinger R
    Breast Cancer Res Treat; 1996; 40(3):257-63. PubMed ID: 8883968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA interstrand cross-linking and cytotoxicity induced by chloroethylnitrosoureas and cisplatin in human glioma cell lines which vary in cellular concentration of O6-alkylguanine-DNA alkyltransferase.
    Beith J; Hartley J; Darling J; Souhami R
    Br J Cancer; 1997; 75(4):500-5. PubMed ID: 9052400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase.
    Malapetsa A; Noë AJ; Poirier GG; Desnoyers S; Berger NA; Panasci LC
    Mutat Res; 1996 Jan; 362(1):41-50. PubMed ID: 8538647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.